GSA Capital Partners’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,012
| Closed | -$144K | – | 1775 |
|
|
2022
Q2 | $144K | Buy |
8,012
+112
| +1% | +$2.01K | 0.02% | 1158 |
|
|
2022
Q1 | $235K | Sell |
7,900
-4,715
| -37% | -$140K | 0.03% | 1069 |
|
|
2021
Q4 | $547K | Buy |
+12,615
| New | +$547K | 0.07% | 534 |
|
|
2021
Q3 | – | Sell |
-1,882
| Closed | -$216K | – | 1679 |
|
|
2021
Q2 | $216K | Sell |
1,882
-349
| -16% | -$40.1K | 0.02% | 1146 |
|
|
2021
Q1 | $232K | Sell |
2,231
-6,276
| -74% | -$653K | 0.04% | 809 |
|
|
2020
Q4 | $407K | Sell |
8,507
-1,545
| -15% | -$73.9K | 0.07% | 555 |
|
|
2020
Q3 | $279K | Buy |
+10,052
| New | +$279K | 0.05% | 792 |
|